Otylia Kowal‐Bielecka
Otylia Kowal‐Bielecka publishes mostly in Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Rheumatology, on topics such as Systemic Sclerosis and Related Diseases, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis and Inflammatory Myopathies and Dermatomyositis.
- World rank
- #703,544 of 7,710,434 ranked researchers
- Rank in Poland
- #4,456 of 100,960
- Works
- 206
- Citations
- 15k
- Citations per work
- 71.5
What does Otylia Kowal‐Bielecka research?
Otylia Kowal‐Bielecka's work is mostly in Medicine (64%), Biochemistry, Genetics and Molecular Biology (6%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences13364.5%
- Medicine13364.5%
- Everything else5426.1%
- Life Sciences199.4%
- 1Pathology and Forensic Medicine33% of their works
- 2Pulmonary and Respiratory Medicine19% of their works
- 3Rheumatology8% of their works
- 4Molecular Biology6% of their works
- 5Epidemiology5% of their works
- 6Immunology4% of their works
Research topics
- Systemic Sclerosis and Related Diseases
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Inflammatory Myopathies and Dermatomyositis
- Pulmonary Hypertension Research and Treatments
- Connective Tissue Growth Factor Research
- Multiple Sclerosis Research Studies
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Which keywords describe Otylia Kowal‐Bielecka's research?
The keywords of their largest research topics: Fibrosis, Autoantibodies, Treatment, Endothelial Dysfunction, TGF-ß Signaling, Pulmonary Involvement, Systemic Sclerosis and Interstitial Lung Disease.
- Systemic Lupus Erythematosus
- Rheumatoid Arthritis
- Inflammation
- Connective Tissue Growth Factor
- Right Heart Assessment
- Inflammatory Myopathies
- TGF-ß
- Interstitial Lung Disease
- Pulmonary Involvement
- Endothelial Dysfunction
- Autoantibodies
- Fibrosis
- Treatment
- TGF-ß Signaling
- Systemic Sclerosis
- Idiopathic Pulmonary Fibrosis
- Dermatomyositis
- Pulmonary Hypertension
- CCN Family
- Diagnostic Criteria
- Multiple Sclerosis
- Antiphospholipid Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Fibrosis2273 topics
- Autoantibodies1934 topics
- Treatment1672 topics
- Endothelial Dysfunction1662 topics
- TGF-ß Signaling1642 topics
- Pulmonary Involvement1441 topic
- Systemic Sclerosis1441 topic
- Interstitial Lung Disease862 topics
- Idiopathic Pulmonary Fibrosis631 topic
- TGF-ß631 topic
- Dermatomyositis231 topic
- Inflammatory Myopathies231 topic
- Pulmonary Hypertension221 topic
- Right Heart Assessment221 topic
- CCN Family201 topic
- Connective Tissue Growth Factor201 topic
- Diagnostic Criteria161 topic
- Inflammation161 topic
- Multiple Sclerosis161 topic
- Rheumatoid Arthritis161 topic
- Antiphospholipid Syndrome101 topic
- Systemic Lupus Erythematosus101 topic
Where does Otylia Kowal‐Bielecka work?
Otylia Kowal‐Bielecka's main affiliation in the publication record is Medical University of Białystok, Poland.
How many publications and citations does Otylia Kowal‐Bielecka have?
OpenAlex counts 206 works and 14,733 citations for Otylia Kowal‐Bielecka, an h-index of 38, ranking #703,544 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Otylia Kowal‐Bielecka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.